{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:14:32Z","timestamp":1788221672356,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the effect of a Best Practice Advisory (BPA) on the ordering and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson\u2019s disease (PD) and related disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with PD are more likely to require hospitalization and are at increased risk of complications. Administration of contraindicated DBA contributes to worsened outcomes in this patient population. Electronic medical record (EMR) warnings (also referred to as BPA) have been proposed as a way to prevent the administration of contraindicated medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A BPA was launched in January 2020 within the University of Rochester EMR system, which alerts the provider when a contraindicated DBA is ordered in hospitalized patients with PD and related disorders. Patients with PD and related disorders hospitalized at two hospitals affiliated to the University of Rochester during a time period before (<jats:italic>t1<\/jats:italic>: 1\/1\/2019\u20131\/1\/2020) and after (<jats:italic>t2<\/jats:italic>: 1\/8\/2020\u20131\/8\/2021) the implementation of the BPA were included in this study. Epic SliderDicer was used to collect the data from the University of Rochester EMR. The number of patients who had contraindicated DBA orders and administrations in both time periods, and the number of patients who had the BPA triggered during <jats:italic>t2<\/jats:italic> were obtained. We compared the results before and after the implementation of the BPA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>306 patients with PD and related disorders were hospitalized during <jats:italic>t1<\/jats:italic> and 273 during <jats:italic>t2<\/jats:italic>. There was significantly less percentage of patients who had contraindicated DBA orders (41.5% in <jats:italic>t1<\/jats:italic> vs. 17.6% in <jats:italic>t2<\/jats:italic>) and patients who had contraindicated DBA administrations (16% in <jats:italic>t1<\/jats:italic> vs. 8.8% in <jats:italic>t2<\/jats:italic>) during <jats:italic>t2<\/jats:italic> (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05 for both comparisons). There was no significant difference between the percentage of patients who had contraindicated DBA orders in <jats:italic>t1<\/jats:italic> and patients with attempted orders (BPA triggered) in <jats:italic>t2<\/jats:italic> (<jats:italic>p<\/jats:italic>\u2009=\u20090.27).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study increase the evidence of the potential benefit of EMR warnings for the optimization of inpatient medication management in patients with PD and related disorders. In particular, our results suggest that EMR warnings help reduce the administration of contraindicated medications, which is a known contributing factor for hospital complications in this patient population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2023.1276761","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T07:39:41Z","timestamp":1702885181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of best practice advisory on the administration of contraindicated medications to hospitalized patients with Parkinson\u2019s disease and related disorders"],"prefix":"10.3389","volume":"15","author":[{"given":"Natalia","family":"Chunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca Y.","family":"Valdovinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene H.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in Parkinson\u2019s disease and parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.parkreldis.2010.11.009","article-title":"Management of the hospitalized patient with Parkinson\u2019s disease: current state of the field and need for guidelines","volume":"17","author":"Aminoff","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12911-017-0430-8","article-title":"Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system","volume":"17","author":"Ancker","year":"2017","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/CPJ.0000000000000709","article-title":"Interventions to minimize complications in hospitalized patients with Parkinson disease","volume":"10","author":"Aslam","year":"2020","journal-title":"Neurol Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mds.10362","article-title":"Prevalence of PD and other types of parkinsonism in three elderly populations of Central Spain","volume":"18","author":"Benito-Le\u00f3n","year":"2003","journal-title":"Mov. Disord."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/mds.27256","article-title":"Prevalence of and indications for antipsychotic use in Parkinson disease","volume":"33","author":"Bower","year":"2018","journal-title":"Mov. Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.parkreldis.2011.03.002","article-title":"Hospitalization in Parkinson disease: a survey of National Parkinson Foundation centers","volume":"17","author":"Chou","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/pgmj.2009.080432","article-title":"Medication management in people with Parkinson\u2019s disease during surgical admissions","volume":"86","author":"Derry","year":"2010","journal-title":"Postgrad. Med. J."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mds.21854","article-title":"Failure of recognition of drug-induced parkinsonism in the elderly","volume":"23","author":"Esper","year":"2008","journal-title":"Mov. Disord."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2377-12-13","article-title":"Deterioration of Parkinson\u2019s disease during hospitalization: survey of 684 patients","volume":"12","author":"Gerlach","year":"2012","journal-title":"BMC Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.parkreldis.2013.04.017","article-title":"Motor outcomes during hospitalization in Parkinson\u2019s disease patients: a prospective study","volume":"19","author":"Gerlach","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mds.23449","article-title":"Clinical problems in the hospitalized Parkinson\u2019s disease patient: systematic review","volume":"26","author":"Gerlach","year":"2011","journal-title":"Mov. Disord."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jopan.2006.09.004","article-title":"Pharmacological prophylaxis and management of adult postoperative\/postdischarge nausea and vomiting","volume":"21","author":"Golembiewski","year":"2006","journal-title":"J. Perianesth. Nurs."},{"key":"ref14","first-page":"10","article-title":"Delayed administration and contraindicated drugs place hospitalized Parkinson\u2019s disease patients at risk","volume":"43","author":"Grissinger","year":"2018","journal-title":"PT"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.parkreldis.2011.12.007","article-title":"Assessment of appropriate medication administration for hospitalized patients with Parkinson\u2019s disease","volume":"18","author":"Hou","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0072-9752(07)83006-5","article-title":"Epidemiology of Parkinson\u2019s disease","volume-title":"Handbook of clinical neurology, Parkinson\u2019s disease and related disorders, part I","author":"Kasten","year":"2007"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2020.05.026","article-title":"Treatment of psychosis in Parkinson\u2019s disease and dementia with Lewy bodies: a review","volume":"75","author":"Kyle","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1136\/ejhpharm-2020-002461","article-title":"Pharmacotherapeutic management of Parkinson\u2019s disease inpatients: how about asking hospital pharmacists?","volume":"28","author":"Lertxundi Etxebarria","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2146\/ajhp060624","article-title":"Antidopaminergic therapy for managing comorbidities in patients with Parkinson\u2019s disease","volume":"65","author":"Lertxundi","year":"2008","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.parkreldis.2015.01.017","article-title":"Measuring the burden and mortality of hospitalisation in Parkinson\u2019s disease: a cross-sectional analysis of the English hospital episodes statistics database 2009\u20132013","volume":"21","author":"Low","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0124356","DOI":"10.1371\/journal.pone.0124356","article-title":"Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson\u2019s disease patients","volume":"10","author":"Martinez-Ramirez","year":"2015","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1212\/WNL.0000000000001745","article-title":"Physician response to a medication alert system in inpatients with levodopa-treated diseases","volume":"85","author":"Morris","year":"2015","journal-title":"Neurology"},{"key":"ref24","year":"2023"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"S414","DOI":"10.1093\/ofid\/ofab466.821","article-title":"623. Exploring \u2018slicer dicer\u2019, an extraction tool in EPIC, for clinical and epidemiological analysis","volume":"8","author":"Saini","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref26","first-page":"51","article-title":"Characteristics of inpatients prescribed dopamine receptor blocking agents","volume":"51","author":"Schwartz","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"ref27","year":"2023"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/mds.20485","article-title":"Emergency hospital admissions in idiopathic Parkinson\u2019s disease","volume":"20","author":"Woodford","year":"2005","journal-title":"Mov. Disord."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1276761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T07:39:46Z","timestamp":1702885186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1276761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":28,"alternative-id":["10.3389\/fnagi.2023.1276761"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1276761","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"article-number":"1276761"}}